Bausch Health Companies Inc. has emerged victorious in a recent legal battle, securing a significant win in a US appeal court to prevent Alvogen from launching a generic version of a popular diarrhea drug. The court's decision upholds Bausch's patent rights and reinforces its position in the pharmaceutical market.
The lawsuit centered around Bausch's patent for the diarrhea drug, which Alvogen sought to challenge by introducing a generic alternative. Bausch argued that Alvogen's product infringed upon its patent, leading to a prolonged legal dispute.
